Bremelanotide for Hypoactive Sexual Desire Disorder

Efficacy and Guidelines

• The National Comprehensive Cancer Network guidelines mention bremelanotide as an option for premenopausal individuals with low sexual desire, noting that while it hasn't been specifically studied in cancer survivors, it may be an appropriate option for some survivors with HSDD 1, 2, 3

Regulatory Status and Usage

• The National Comprehensive Cancer Network (NCCN) guidelines note that bremelanotide significantly improves sexual desire and reduces distress related to low sexual desire compared to placebo in clinical trials, although the strength of evidence is not specified 1